Universitaetsklinikum Augsburg — Clinical Trial Site

182 Registered trials

91 Currently recruiting

Organisation

Universitaetsklinikum Augsburg

Location

Augsburg, Germany

Identifier

ORG-100029226

Address

Stenglinstrasse 2, Kriegshaber, 86156, Germany

Departments

"Schwäbisches Kinderkrebszentrum Kinderkrebsforschungszentrum"
#2052:II. Medizinische Klinik
#3144: Klinik für Frauenheilkunde und Geburtsmedizin
1408: Haematologie,Onkologie
1906:Klinik für Kinder- und Jugendmedizin
2057: Klinik für Kinder- und Jugendmedizin
2515: II Medizinische Klinik
2614: Klinik für Urologie
3131:Klinik für Nuklearmedizin
Anesthesiology and Intensive Care Medicine
Apotheke
Children’s Cancer Center
Clinic for Children and Adolescent Medicine
Clinic for Dermatology, Venerology and Allergology
Clinic for Paediatric and Adolescent Medicine
Comprehensive Cancer Center Augsburg - CCCA
DE10032: Klinikum Augsburg - III. Med. Klinik
Department o Medicine II, Hematology/Oncology
Department of Anesthesiology and Intensive Care Medicine
Department of Dermatology
Department of Medicine II
Dept. für Dermatologie und Allergologie
Dermatologie
Dermatology
Dermatology and Allergology
DermatoOncology
Frauenklinik
Gastroenterologie
Gastroenterology
Gastrointestinale Onkologie
Gynecology
Gynecology and Obstetrics
Hämatologie / Onkologie
Hochschulambulanz für Strahlentherapie und Radioonkologie
I. Klinik fuer Kinder und Jugendliche
I. Medizinische Klinik
II Deparment of internal medicine, Hematology/ Oncology
II Department of Internal Medicine, Hematology / Oncology
II Medical Clinic Hematologic, Oncologic Department
II Medizinische Klinik Hämatologie/ Onkologie
II. Klinik für Kinder und Jugendliche
II. Med. Klinik
II. Medical Clinic
II. Medical Clinic - Haematology/Oncology
II. Medizinische Klinik
II. Medizinische Klinik Hämatologie und Internistische Onkologie
II. Medizinische Klinik Cancer Center Augsburg
II. Medizinische Klinik für Innere Medizin, Hämatologie, Onkologie, Palliativmedizin
II. Medizinische Klinik, Haematologie, internistische Onkologie und Haemostaseologie
II. Medizinische Klinik, Hämatologie, Onkologie
II. Medizinische Klinik, Hämatologie/Onkologie
II.medizinische Klinik/Hämatologie, Onkologie
III med Klinik
III Medizinische Klinik / Gastroenterologie und Gastrointestinale Onkologie
III. Med. Klinik
III. Medical Clinic, Gastroenterology
III. Medizinische Klinik
III. Medizinische Klinik; Hämatologie und Internistische Onkologie
Innere Medizin Schwerpunkt Hämatologie und Onkologie
Innere Medizin und hämatologie und Onkologie in Augsburg
Innere Medizin, Haematologie und Onkologie
Internal Medicine
Internal Medicine, Haematology and Oncology
Kinderklinik
Klinik fuer Dermatologie
Klinik fuer Dermatologie und Allergologie
Klinik fuer Hals-, Nasen-, und Ohrenheilkunde
Klinik fuer Kinder- und Jugendmedizin
Klinik fuer Neurochirurgie
Klinik fuer Urologie
Klinik für Anästhesiologie und Operative Intensivmedizin
Klinik für Dermatologie
Klinik für Dermatologie und Allergologie
Klinik für Dermatologie und Allergologie, Campus Süd
Klinik für Frauenheilkunde
Klinik für Frauenheilkunde und Geburtshilfe
Klinik für Frauenheilkunde und Geburtsmedizin
Klinik für Kinder- und Jugendliche
Klinik für Kinder- und Jugendmedizin
Klinik für Kinder- und Jugendmedizin Schwäbisches Kinderkrebszentrum
Klinik für Kinder- und Jugendmedizin, Schwäbisches Kinderkrebszentrum
Klinik für Neurologie und klinische Neurophysiologie
Klinik für Nuklearmedizin
Klinik für Strahlentherapie
Klinik für Urologie
Medizinische Klinik II
Medizinische Klinik II, Stammzelltransplantation
Medizinische Klinik III
N/A
NA
Neuroradiologie
Nuclear Medicine
Paedriatrics, Department of Oncology and Hematology
Pediatric Hematology/Oncology
Pediatrics and adolescent medicine
Pedriatrics
Schwäbisches Kinderkrebszentrum
Schwäbisches Kinderkrebszentrum I. Klinik für Kinder und Jugendliche Hämatologie / Onkologie
Schwäbisches Kinderkrebszentrum Kinderkrebsforschungszentrum
Universitaetsklinikum Augsburg
Universitätsklinikum Augsburg A.ö.R.
Universitätsklinikum Augsburg Brustzentrum
Universitätsklinikum Augsburg, II. Medizinische Klinik-Hämatologie, Onkologie
University Hospital Augsburg III. med. Clinic

Clinical trials at this site (182)

Search interface

A Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) vs Investigator’s Choice in Participants… Recruiting

2024-519152-82-00 Relapsed/Refractory Follicular Lymphoma 5 2025-09-03
Darolutamide and bipolar androgen therapy for mCRPC patients (DaroBAT) Recruiting

2025-521051-23-00 metastatic castration-resistant prostate cancer 4 2025-08-06
A trial comparing the treatment of rilvegostomig with fluoropyrimidine and trastuzumab deruxtecan to the standard treatment in patients with… Recruiting

2024-512583-57-00 HER2-positive locally advanced or metastatic gastric or 5 2025-07-30
A Study of BGB-16673 Compared to Investigator’s Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab or Venetoclax Plus Rituxima… Recruiting

2024-518893-15-00 Chronic lymphotic leukemia and Small Lymphocytic lympho 5 2025-07-29
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia Recruiting

2024-520154-38-00 Acute Myeloid Luekemia 5 2025-07-29
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients with Coronavirus Disease 2019 (COVID-19) who ar… Recruiting

2024-517727-39-00 Covid-19 at high risk of progression to severe illness. 5 2025-07-28
Recombinant coagulation Factor VIIa administered at the earliest time for the treatment of stroke caused by bleeding in the brain - FASTEST… Recruiting

2024-517383-28-00 Acute haemorrhagic stroke 5 2025-07-21
VyClo ITCC-092 Recruiting

2023-508050-26-00 AML 3 2025-07-17
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab – A randomized, placebo-controlled, double-blin… Recruiting

2023-506887-15-00 Hepatocellular carcinoma 4 2025-07-14
Pembrolizumab in combination with lenvatinib in patients with recurrent, persistent, metastatic or locally advanced vulvar cancer not amenab… Recruiting

2024-515646-16-00 Recurrent, persistent, metastatic or locally advanced v 4 2025-06-24
Sequential Gilteritinib in Combination with Venetoclax and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mut… Recruiting

2023-507878-41-00 Acute myeloid leukemia 4 2025-04-25
Pre-Operative Treatment in rEseCTable cOlon canceR (PROTECTOR/FIRE-10; AIO-KRK-0620; IAG-VO-0323) Prospective, randomized, open-label, multi… Recruiting

2023-508076-11-00 Colon cancer staged T3-4 and/or nodal positive by CT an 5 2025-04-01
Reduction of occurence of Acute Kidney Injury through administration of angiotensin II versus Noradrenaline Recruiting

2024-517771-21-00 Acute kidney injury 11 2025-03-31
PROTamine Application in patients underGOing tRAnScatheter aortic valve replacement (PROTAGORAS) Recruiting

2024-512024-10-01 Adult patients with severe aortic stenosis scheduled fo 5 2025-03-28
not applicable Recruiting

2023-508953-16-00 Newly diagnosed high grade glioma (HGG) including diffu 4 2024-10-25
A multicenter, single-arm phase II study to assess the safety, tolerability, and efficacy of Isatuximab in adult patients with cytologic or … Recruiting

2023-507899-47-00 Cytologic or molecular relapsed/refractory CD38 positiv 4 2024-10-22
NeoAdjuvant study comparing sacituzumab govitecan versus sacituzumab govitecan+pembrolizumab treatment in low-risk, triple-negative early br… Recruiting

2023-508787-29-00 Triple-negative early breast cancer with low risk for r 4 2024-10-10
A trial to evaluate the efficacy and safety of oral controlled-ileocolonic-release nicotinamide (CICR-NAM) in patients with mild to moderate… Recruiting

2024-510807-13-00 ulcerative colitis 10 2024-09-12
Long-term clinical trial of PQ Grass in paediatric subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by grass poll… Recruiting

2023-508520-36-00 Seasonal allergic rhinitis/rhinoconjunctivitis induced 5 2024-09-06
An International, Prospective, Open-label, Multi-center, Randomized Phase III Study comparing lutetium (177Lu) vipivotide tetraxetan (AAA617… Recruiting

2022-502956-29-00 Oligometastatic prostate cancer (OMPC) 5 2024-07-01
A Phase 3 study of Dostarlimab as Sequential Therapy after Chemoradiation compared to placebo in adult participants with Locally Advanced Un… Recruiting

2023-508613-17-00 Neoplasms, Head and Neck 5 2024-05-29
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a p53 Y220C Mutation (PYNNACLE) Recruiting

2023-504251-27-00 Locally Advanced or Metastatic Solid Tumors Harboring a 7 2024-05-27
PRIDE – PRotective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma Recruiting

2024-514865-20-00 Glioblastoma 4 2024-04-10
Venetoclax plus azacitidine versus standard intensive chemotherapy for patients with newly diagnosed acute myeloid leukemia (AML) and NPM1 m… Recruiting

2024-515267-59-00 Acute myeloid leukemia 4 2024-04-07